Aurobindo, Lannett to sell assets for merger nod
Drugmaker Aurobindo Pharma must sell four products to complete its $250 million acquisition of generics drug company Lannett, according to the Federal Trade Commission....To view the full article, register now.
Already a subscriber? Click here to view full article